The Broad Institute and Rockefeller University disagree over which scientists should be named as inventors on certain patents involving the gene-editing technology.
August 8, 1988|
How will startups get needed capital if the licenses they grant can be voided during court proceedings? WASHINGTON—Steven Mendell says he isn’t worried about the future of his company, Xoma Corp. The seven-year-old Berkeley, California, biotechnology startup firmed up its funding by going public in 1986 and has an agreement with the pharmaceutical giant Pfizer Inc. to help it develop a line of monoclonal antibody-based products to treat septic shock infections. But Mendell, Xoma&